Treatment of Myotonia - Lamotrigine Versus Namuscla
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
In this clinical study, the aim is to investigate whether there is a difference in treatment
of myotonia using two drugs. A difference there can justify the significantly higher cost
when treated by Namuscla versus Lamotrigine.
According to the current corona pandemic, the investigators designed an app to use for data
collection in the study. The app also ensures that patients who live far from the clinic more
easily can participate.
Phase:
N/A
Details
Lead Sponsor:
Grete Andersen, MD
Collaborators:
Danish Region GCP-Copenhagen Lupin Atlantis Holdings S.A. Region Capital Denmark ZiteLab